Melbourne Clinical Trials

The Neuron Study

The purpose is to trial a potential new treatment for Amyotrophic lateral sclerosis (ALS).

12 nights
1 visits

The Neuron Study is researching a potential new treatment for various neurological conditions, including neurodegeneration - diseases that affect the nerve cells of the brain.

More than 342,000 Australians are currently affected by various neurodegenerative related diseases. With this number only expected to grow in the future, it's crucial that treatment and preventative care can be established.

The study medication is administered twice as an oral tablet and is designed to prevent neurodegeneration that causes conditions like Glaucoma, Alzheimer's & Parkinson's.

This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.

Call us on 1800 243 733 to discuss your eligibility today!

Eligibility

Biological Sex Male or Female
Age 18-55 years old
BMI 18–32 kg/m²
Medical History No significant medical history
Medications Not taking any prescription medication
Smoking History Non-smokers or social smokers up to 5 cigarettes per day